It has been reported that the urine of patients with prolidase deficiency contains various iminodipeptides with a carboxyl-terminal proline (hydroxyproline). These iminodipeptides have hitherto been detected indirectly by acid hydrolysis or enzymatic digestion, followed by amino acid analysis. In the present study, it was shown that X-Pro could be distinguished from Pro-X when the iminodipeptides were analysed directly by liquid chromatography coupled with atmospheric pressure ionization mass Spectrometry (LC/API-MS), with scanning of the protonated molecule ions ([M + H]+). The same procedure also successfully quantified urinary iminodipeptides from patients with prolidase deficiency. A quantitative investigation of two siblings with prolidase deficiency revealed that the patient with severe clinical symptoms excreted more iminodipeptides than the other who did not have serious symptoms. LC/API-MS also revealed iminodipeptides (Gly-Hyp and Pro^Hyp) in the urine of the mother of the patients and in normal volunteers. Patients excreted much more Pro-Hyp than normal volunteers, whereas no quantitative differences were found between the mother and controls. In patients, the excretion of large quantities of X-Pro is due to their very low prolidase activity towards this type of substrate. In the erythrocytes of patients, prolidase activity towards X-Hyp was extremely low; even in the mother and normal volunteers, it was remarkably low in comparison with the activity against X-Pro.
Introduction
-.
-t,., ,, -j i_ j ι · the ammo acids liberated by acid hydrolysis or enProlidase (EC 3.4.13.9) 1 ) is expressed in all human zymatic digestion, using an amino acid analyser (3, tissues, and it catalyses the hydrolysis of iminodipep-6, 7) or isotachophoresis (8) . These methods gave tides with a C-terminal prolyl residue. Prolidase de-only indirect qualitative analyses, and an exact idenficiency (1 -5) is a rare autosomal recessive disease tification and quantification have never been reaffecting collagen metabolism, characterized by ported. chronic ulcerative dermatitis and mental retardation. TT . , " ,. . , , It has been reported that patients with prolidase deHlgh Performance hqmd chromatography (HPLC) is ficiency, initially named iminopeptiduria, excrete large °n e °f the ™ st f^ive means of separating peptide amounts of iminodipeptides containing a C-terminal IBCrtuiei . < 9) and HPLC connected to atmospheric proline or hydroxyproline in the urine (6, 7) . Urinary P ressure '°n izat ' on ma *> Spectrometry (LC/API-MS) iminodipeptides have been identified by analysis of !«» »ceiuy attracted considerable attention as a new analytical method in various fields (10, 17) . In con-_ trast to gas chromatography-mass Spectrometry, sam-') Enzyme: Prolidase (peptidase D, imidodipeptidase, EC P' es ^° not nee<^ to be derivatized for LC/API-MS, 3.4.13.9) which can rapidly analyse even substances easily af-fected by heat. This procedure shows promise for the analyses of compounds in biological samples. A previous paper (11) ). In the present study it was investigated whether authentic iminodipeptides containing a Cterminal proline could be distinguished from those containing an N-terminal proline, using LC/API-MS. The procedure was also used for the quantitative analyses of the urinary iminodipeptides in prolidase deficiency. Urine samples from the mother of affected patients and from normal volunteers were also scanned for iminodipeptides.
It was discovered by Powell et al. that iminopeptiduria was the result of an enzyme defect, and that prolidase deficiency could be diagnosed by the assay of prolidase activity in erythrocytes, leukocytes and cultured skin fibrobi sts. Furthermore, two isozymes of prolidase (prolidase I and II) in normal humans have been studied. Prolidase I has a relative molecular mass of about 112000 and the highest activity towards GlyPro, whereas prolidase II has a relative molecular mass of about 185000 and is mainly active towards Met-Pro. Characteristics of the isozymes in patients and controls have been discussed in detail (12) (13) (14) (15) (16) . The present paper also reports the prolidase activities for X-Hyp in patients, in their mother and in controls, which are closely correlated with the quantities of XHyp excreted in the urine.
Materials and Methods

Reagents
Synthetic iminodipeptides containing a C-terminal proline or hydroxyproline (Gly-Pro, Ala-Pro, Val-Pro, Leu-Pro, Pro-Pro, Ser-Pro, Gly-Hyp and Pro-Hyp) and iminodipeptides containing an N-terminal proline (Pro-Gly, Pro-Ala and Pro-Leu) were purchased from Sigma Chemical Company (St. Louis, MO, USA). The protein assay kit was from Pierce (Rockford, IL, USA), and the urinary creatinine assay kit was from Wako Pure Chemical Industries Ltd. (Osaka, Japan). All other chemicals were of analytical grade.
Apparatus
A Hitachi L-6200 high-performance liquid Chromatograph (HPLC) was connected to a Hitachi M-80B double-focussing mass spectrometer through an atomospheric pressure ionization interface (11, 17) . LC/API-MS data were obtained with a Hitachi M-0101 data acquisition system. Qualitative and quantitative analyses of a variety of iminodipeptides were carried out under the following conditions. Inertsil ODS reverse-phase packed columns (4.6 mm ID χ 150 mm or 4.6 mm ID χ 250 mm) from Gasukuro Kogyo Ltd. (Tokyo, Japan) were used for the HPLC. Trifluoroacetic acid (lg/1): methanol (75 + 25, by vol.) was used as the mobile phase at a flow rate of 0.9 ml/ min. Nebulizer temperature, desolvator temperature and drift voltage were 255 °C, 390 °C and 225 V, respectively.
Samples
Blood was taken from two patients (sisters) with prolidase deficiency, from their mother and from controls (laboratory personnel) into heparinized tubes. The erythrocytes were isolated by Umemurcfs method (4) and stored at -80 °C until use. Urine samples from patients, their mother and controls were taken into bottles containing a small amount of 2 mol/1 hydrochloric acid and toluene, and kept at -20 °C until use.
Isolation of iminodipeptides from urine
Urine samples (3 ml) from the two patients, their mother and normal volunteers were weakly acidified with 2 mol/1 acetic acid and filtered. The filtrate was transferred to a column (0.9 χ 20 cm) containing a cation-exchange resin (Diaion SK-1, Hrform, 100 ~ 200 mesh, Mitsubishi Kasei Kogyo Ltd., Tokyo, Japan), washed with 30 ml of water, and eluted with 30 ml of 2 rnol/1 ammonia. The eluate was evaporated to dryness under reduced pressure. The residue was dissolved in 1 ml of water, then subjected to LC/API-MS. The creatinine concentration in each urine sample was determined using the kit described above.
Assay of prolidase activity
Erythrocyte lysates were prepared from the heparinized blood of patients and normal volunteers according to Umemurcfs method (4). A mixture containing 10 μΐ of diluted erythrocyte lysates, 10 μΐ of 10 mmol/1 MnCl 2 and 80 μΐ of 50 mmol/1 Tris-HC1 (pH 7.8) was preincubated for 10 rnin at 37 °C, then incubated with 100 μΐ of 10 mmol/1 substrate (X^Pro) in 1 mmol/1 MnCl 2 for 30 min at 37 °C. The reaction was terminated by the addition of 200 μΐ of 100 g/1 trichloroacetic acid solution. After 10 min at 90 °C with Chinarcfs reagent (18) which consisted of liinhydrin, phosphoric acid and acetic acid, liberated proline was estimated by spectrophotometry (wavelength: 515 nm). The activity towards X-Hyp was assayed similarly, but after the addition of trichloroacetic acid was centrifuged at 3000 min" 1 for 5 min. Supernatant (0.5 ml) was then incubated with 2.5 g/1 copper sulphate, 100 g/1 sodium hydroxide and 1.8 mol/1 hydrogen peroxide (0.5 ml of each) for 5 min at room temperature, then for 5 min at 80 °C. After cooling the mixture to 0 °C, 2 ml of 0.75 mol/1 sulphuric acid and 1 ml of 50 g/1 /7-dimethyl-aminobenzaldehyde were added and the mixture was incubated for 10 min at 70 °C. The absorbance of the solution was measured at 575 nm.
Results
The sensitive detection of authentic iminodipeptides containing C-terminal proline by scanning their protonated molecule ions ([M + H]+) by LC/API-MS has been reported previously (11) . There are two types of imiriodipeptide, i. e. with a C-terminal or an Nterminal proline. Thus we determined whether LC/ API-MS could distinguish iminodipeptides containing a C-terminal from those containing an N-terminal proline. The iminodipeptide pairs Pro-Gly/Gly-Pro, Pro-Ala/Ala-Pro and Pro-Leu/Leu-Pro have the same protonated molecule mass (m/e) of 173, 187 and 229 respectively. The mass chromatograms and mass spectra of these pairs are presented in figure 1 . The two peaks of each pair were clearjy separated, showing the difference of retention time on mass chromatograms. Pro-Gly and Pro-Ala were eluted earlier than fig. 1) . The previous report (11) showed the peaks produced by various urinary iminodipeptides from a patient with prolidase deficiency. On the basis of the present study, it now seems certain that those urinary iminodipeptides contained a C-terminal proline.
Good correlations were obtained between the concentrations of synthetic iminodipeptides and the peak areas on mass chromatograms, so that the calibration curves were linear ( fig. 2) . Quantification of some standard iminodipeptides applied to the cation-exchange columns demonstrated approximately 95% recovery, and standards added to normal urine also showed a recovery of 90 ~ 95% (data not shown). Urine samples from patients with prolidase deficiency were passed through the column, and the effluent was monitored for selected ions (selected ion monitoring, respect to Gly-Hyp, patients excreted much more ProHyp than either their mother or normal volunteers. No differences in Gly-Hyp or Pro-Hyp excretion were found between normal volunteers and the patients' mother, who was heterozygous for the prolidase gene (19) . As enzymatic activity and excretion of iminodipeptides in the urine are closely related, prolidase activity, particularly towards X^Hyp, is worthy of note. Therefore prolidase activities against X-Pro and X-Hyp in erythrocytes from patients, the mother and normal volunteers were determined by the method described under Materials and Methods. The prolidase activities of patients towards Gly-Pro and Pro-Pro were very low compared with controls, and the mother had approximately half as much activity as normal volunteers, which agreed with a previous report (19) . The prolidase activities of patients towards Gly-Hyp and Pro-Hyp were much lower than those towards GlyPro and Pro-Pro. It was also found that even in normal volunteers, prolidase activities towards GlyHyp and Pro-Hyp are extremely low, and that the prolidase activities of the patients' mother towards both X-Hyp and X-Pro are about one half of the control values (tab. 2). 
Discussion
Previously used procedures employing acid hydrolysis or enzymatic digestion, followed by amino acid analysis, were unable to directly identify and quantify iminodipeptides containing a C-terminal proline or hydroxyproline in the urine of patients with hereditary prolidase deficiency. However, the LC/API-MS system used in this study distinguished between X-Pro and Pro-X on a mass chromatogram and mass spectrum, and is therefore suitable for the exact identification of urinary iminodipeptides. This apparatus, moreover, performed rapid simultaneous quantitative analyses of several iminodipeptides. Quantification of urinary iminodipeptides (X-Pro) revealed that a patient with severe dermatitis excreted more iminodipeptides than her younger sibling with few clinical symptoms. Collagen metabolism can be closely related to inflammation, and it may be reflected in the excretion of iminodipeptides in urine. Human prolidase consists of two isozymes (prolidase I and II) which are different in substrate specificity and in some biochemical characteristics. Prolidase deficiency involves a complete deficiency of prolidase I, which shows the highest activity towards Gly-Pro. Prolidase* II, which is active mainly against Met-Pro, shows the same activity in patients as in normal controls. Complete digestion of Met-Pro by prolidase II seems to be the reason why Met-Pro cannot be detected at all in urine samples from patients (tab. 1). The present investigations revealed that not only the patients but also their mother and normal volunteers excreted Gly-Hyp and Pro-Hyp into the urine. The patients excreted more Pro-Hyp than either their mother or controls. There was little difference between the excretion of Gly-Hyp by patients and controls.
and this may reflect the limited production of GlyHyp from collagen, which contains far more Pro-Hyp than Gly-Hyp. Furthermore, there was no quantitative difference between the X-Hyp excretion of mother and controls (tab. 1-B). This interesting finding is in agreement with the measured prolidase activities. The assay of prolidase activities towards Gly-Pro, GlyHyp, Pro-Pro and Pro-Hyp in the erythrocytes of patients, their mother and controls showed that the patients' prolidase (prolidase II) activities towards Gly-Hyp and Pro-Hyp were much lower than those towards Gly-Pro and Pro-Pro, which in turn were very low compared with those of controls. Even in controls, prolidase (prolidase I and II) activities towards Gly-Hyp and Pro-Hyp were extremely low in comparison with those towards Gly-Pro and Pro-Pro. The mother's prolidase activities towards X-Pro and X-Hyp were about one half of those of normal controls (tab. 2). These results suggest that the mother's halved activities can hydrolyse all the iminodipeptides containing a C-terminal proline, which are produced by the metabolism of collagen, so that X-Pro cannot be detected in her urine. However, low prolidase activities towards X-Hyp in the mother and normal volunteers were not sufficient for 1 the hydrolysis of all the endogenous iminodipeptides containing a C-terminal hydroxyproline, so that small amounts of unhydrolysed Gly-Hyp and Pro-Hyp are found in their urines.
This report shows that LC/API-MS (SIM mode) is very suitable for the detection and quantification of urinary peptides, even in very small amounts.
